Nanoparticles Engineered With Rituximab and Loaded With Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-13-0015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)


Related search